| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |